全文获取类型
收费全文 | 172541篇 |
免费 | 44928篇 |
国内免费 | 426篇 |
专业分类
耳鼻咽喉 | 2157篇 |
儿科学 | 5711篇 |
妇产科学 | 1020篇 |
基础医学 | 30926篇 |
口腔科学 | 10016篇 |
临床医学 | 18187篇 |
内科学 | 37664篇 |
皮肤病学 | 5639篇 |
神经病学 | 23133篇 |
特种医学 | 7316篇 |
外国民族医学 | 1篇 |
外科学 | 26901篇 |
综合类 | 2911篇 |
现状与发展 | 1篇 |
一般理论 | 13篇 |
预防医学 | 12554篇 |
眼科学 | 2460篇 |
药学 | 13108篇 |
18篇 | |
中国医学 | 3985篇 |
肿瘤学 | 14174篇 |
出版年
2023年 | 546篇 |
2022年 | 915篇 |
2021年 | 3375篇 |
2020年 | 6995篇 |
2019年 | 16144篇 |
2018年 | 16016篇 |
2017年 | 15249篇 |
2016年 | 12000篇 |
2015年 | 11839篇 |
2014年 | 12290篇 |
2013年 | 12591篇 |
2012年 | 11348篇 |
2011年 | 11482篇 |
2010年 | 10012篇 |
2009年 | 6254篇 |
2008年 | 6856篇 |
2007年 | 5194篇 |
2006年 | 4943篇 |
2005年 | 4599篇 |
2004年 | 4355篇 |
2003年 | 4043篇 |
2002年 | 3667篇 |
2001年 | 2960篇 |
2000年 | 1703篇 |
1999年 | 579篇 |
1998年 | 222篇 |
1997年 | 215篇 |
1996年 | 186篇 |
1995年 | 186篇 |
1994年 | 151篇 |
1993年 | 138篇 |
1992年 | 132篇 |
1991年 | 129篇 |
1990年 | 76篇 |
1989年 | 83篇 |
1987年 | 79篇 |
1986年 | 72篇 |
1985年 | 2823篇 |
1984年 | 3370篇 |
1983年 | 2859篇 |
1982年 | 3323篇 |
1981年 | 3018篇 |
1980年 | 2509篇 |
1979年 | 2496篇 |
1978年 | 2060篇 |
1977年 | 1529篇 |
1976年 | 1991篇 |
1975年 | 1511篇 |
1974年 | 1322篇 |
1973年 | 1271篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features 下载免费PDF全文
43.
44.
45.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):25-34
PurposeTo investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).Materials and MethodsThis single-center retrospective study included 26 consecutive patients with HCC who received checkpoint inhibitor immunotherapy within 90 days of radioembolization from April 2015 to May 2018. Patients had preserved liver function (Child-Pugh scores A–B7) and either advanced HCC due to macrovascular invasion or limited extrahepatic disease (21 patients) or aggressive intermediate stage HCC that resulted in earlier incorporation of systemic immunotherapy (5 patients). Clinical documentation, laboratory results, and imaging results at 1- and 3-month follow-up intervals were reviewed to assess treatment-related adverse events and treatment responses.ResultsThe median follow-up period after radioembolization was 7.8 months (95% confidence interval [CI], 5.6–11.8). There were no early (30-day) mortality or grades 3/4 hepatobiliary or immunotherapy-related toxicities. Delayed grades 3/4 hepatobiliary toxicities (1–3 months) occurred in 2 patients in the setting of HCC disease progression. One patient developed pneumonitis. The median overall survival from first immunotherapy was 17.2 months (95% CI, 10.9–23.4). The median overall survival from first radioembolization was 16.5 months (95% CI, 6.6–26.4). From first radioembolization, time to tumor progression was 5.7 months (95% CI, 4.2–7.2), and progression-free survival was 5.7 months (95% CI, 4.3–7.1).ConclusionsRadioembolization combined with checkpoint inhibitor immunotherapy in cases of HCC appears to be safe and causes limited treatment-related toxicity. Future prospective studies are needed to identify the optimal combination treatment protocols and evaluate the efficacy of combination therapy. 相似文献
46.
47.
Assessment of Myocardial Infarct Size by Three‐Dimensional and Two‐Dimensional Speckle Tracking Echocardiography: A Comparative Study to Single Photon Emission Computed Tomography 下载免费PDF全文
48.
49.
50.
Angela Mauro Salvatore Mauro Roberto Rega Luigi Martemucci Rita Sottile 《Pediatric dermatology》2019,36(1):e34-e36
Henoch‐Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11‐year‐old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology. 相似文献